Overview


According to FutureWise analysis the market for Europe Antimicrobial Susceptibility Testing in 2023 is US$ 1.16 billion, and is expected to reach US$ 1.8 billion by 2031 at a CAGR of 5.50%.

Antimicrobial susceptibility testing (AST) is a laboratory technique used to assess the efficacy of antibiotics and other antimicrobial agents against a particular microorganism. This testing is important because it provides critical information to guide the selection of appropriate antimicrobial therapy for bacterial, fungal, and viral infections. AST involves the exposure of the microorganism to various concentrations of antimicrobial agents in vitro and the subsequent determination of the minimum inhibitory concentration (MIC) required to inhibit or kill the organism. The MIC is the lowest amount of an antimicrobial agent that can inhibit the growth of the microorganism.

AST can be performed using different methods, including disk diffusion, broth microdilution, agar dilution, and gradient diffusion. The disk diffusion method involves placing paper disks impregnated with different antimicrobial agents onto a bacterial culture plate and measuring the size of the zone of inhibition around the disk. The broth microdilution method involves preparing serial dilutions of the antimicrobial substance in a liquid growth medium and then inoculating the dilutions with the microorganism of interest. Agar dilution involves preparing a series of agar plates, each containing a different concentration of the antimicrobial agent. The plates are inoculated with the microorganism, and the MIC is determined. Gradient diffusion involves using plastic strips impregnated with a gradient of the antimicrobial agent. The strips are placed on an agar plate inoculated with the microorganism, and the MIC is determined by identifying the concentration of the antimicrobial agent where the gradient intersects with the growth of the microorganism.

FutureWise Market Research has published a report that provides an insightful analysis of Antimicrobial Susceptibility Testing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Antimicrobial Susceptibility Testing Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • BioMérieux
  • BD
  • Danaher
  • Thermo Fisher
  • Bio-Rad Laboratories
  • Hi-Media
  • Merlin
  • Liofilchem
  • Accelerate
  • Alifax
  • Creative Diagnostics
  • Merck Group
  • Synbiosis
  • Bioanalyse
  • Zhuhai DL Biotech.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Antimicrobial Susceptibility Testing Market:

  • In May 2022, NanoSynex Ltd., a business in which Qualigen recently finalised arrangements to acquire a controlling ownership, was highlighted at BioMed Israel, according to an announcement from Qualigen Therapeutics. Innovative technology developed by NanoSynex aims to six-fold accelerate the turnaround time for antimicrobial susceptibility test results.

The antimicrobial susceptibility testing (AST) market is dynamic and is influenced by various factors, such as the prevalence of infectious diseases, technological advancements, and government initiatives. One of the major factors influencing the growth of the AST market is the increasing incidence of infectious diseases worldwide. The emergence of new strains of drug-resistant bacteria and the increasing use of antibiotics has increased the demand for AST products and services. The development of new and advanced technologies is also driving the growth of the AST market. Advances in proteomics and genomics have led to the development of new diagnostic tools that can identify pathogens and their resistance mechanisms quickly and accurately. This has resulted in improved patient outcomes and reduced healthcare costs. Government initiatives and policies are also playing a critical role in the growth of the AST market. Several governments worldwide have implemented programs to promote the rational use of antibiotics and prevent the spread of antibiotic-resistant infections. These initiatives have led to increased demand for AST products and services.

However, the high cost of AST products and services remains a major challenge for the market. The high cost of these products and services limits their accessibility, particularly in low-income countries with a high burden of infectious diseases. Moreover, the lack of standardization in AST procedures and the emergence of new resistance mechanisms pose significant challenges for the market. Developing standardized testing procedures and implementing quality control measures are essential to ensure accurate and reliable results.

Overall, the AST market is dynamic, and it is anticipated to expand throughout the forecast period due to the rising prevalence of infectious illness, the development of new and innovative technologies, and government initiatives to promote the rational use of antibiotics. However, the market faces significant challenges that must be addressed to ensure its growth and sustainability.

By Product

  • Automated Laboratory Instruments
  • Manual Antimicrobial Susceptibility Testing Products
    •    Susceptibility Testing Disks
    •    MIC Strips
    •    Susceptibility Plates
  • Culture and Growth Media
  • Consumables

By Method

  • Dilution
  • Disk Diffusion
  • ETEST
  • Automated Antimicrobial Susceptibility Testing
  • Genotypic Methods

By Type

  • Antibacterial Testing
  • Antifungal Testing
  • Antiparasitic Testing
  • Other Susceptibility Testing

By Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Other Applications

By End User

  • Diagnostic Centers and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Research and Academic Institutes 

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share of 35% in the global market in 2022. One of the main reasons is the high prevalence of infectious diseases in this region, which has created a significant demand for AST products and services. In addition, North America has a well-established healthcare infrastructure and a strong focus on research and development in the field of healthcare. This has led to the development of advanced technologies and innovative products in the AST market, further boosting the demand for these products. Moreover, the presence of key market participants in the AST market, such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Becton, Dickinson and Company, among others, has also contributed to the dominance of this region in the market. Additionally, based on end-user; the hospitals and diagnostic center segment accounted for the majority revenue share, and based on product type; the automated instruments segment is predicted to grow with the highest CAGR. Furthermore, at FutureWise, we also offer customization in the region segment based on your requirements. Kindly, share your requirement at


  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antimicrobial Susceptibility Testing Market By Product, By Method, By Type, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antimicrobial Susceptibility Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antimicrobial Susceptibility Testing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antimicrobial Susceptibility Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antimicrobial Susceptibility Testing Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Automated Laboratory Instruments
        2. Manual Antimicrobial Susceptibility Testing Products
         2.1. Susceptibility Testing Disks
         2.2. MIC Strips
         2.3. Susceptibility Plates
        3. Culture and Growth Media
        4. Consumables

  • 8.   Antimicrobial Susceptibility Testing Market, By Method Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dilution
        2. Disk Diffusion
        3. ETEST
        4. Automated Antimicrobial Susceptibility Testing
        5. Genotypic Methods

  • 9.   Antimicrobial Susceptibility Testing Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Antibacterial Testing
        2. Antifungal Testing
        3. Antiparasitic Testing
        4. Other Susceptibility Testing

  • 10.   Antimicrobial Susceptibility Testing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Epidemiology
        4. Other Applications

  • 11.   Antimicrobial Susceptibility Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Centers and Hospitals
        2. Pharmaceutical and Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Research and Academic Institutes

  • 12.   North America Antimicrobial Susceptibility Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Antimicrobial Susceptibility Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Antimicrobial Susceptibility Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Antimicrobial Susceptibility Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Antimicrobial Susceptibility Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. bioMérieux
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BD
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Danaher
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hi-Media
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. MERLIN
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Liofilchem
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Accelerate
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Alifax
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Creative Diagnostics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Merck Group
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Synbiosis
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Bioanalyse
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Zhuhai DL Biotech
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

FAQ


Antimicrobial Susceptibility Testing is a laboratory procedure used to determine the effectiveness of antibiotics against specific pathogens. It guides clinicians in choosing the most appropriate antibiotic treatment for infections, thereby ensuring effective patient care and combatting antibiotic resistance.

Key trends in the market include advancements in rapid testing methods, an increased focus on multidrug-resistant organisms, and the integration of artificial intelligence to predict antimicrobial resistance patterns. Our report explores these trends in depth, providing data-backed insights into their implications for the market.

The Antimicrobial Susceptibility Testing research report contributes valuable data on the existing resistance patterns and the effectiveness of current antibiotics. This information is vital for pharmaceutical companies and researchers in the development of new treatments that are needed to combat resistant strains of microorganisms.

Antimicrobial susceptibility testing and antibiotic sensitivity testing are terms that are often used interchangeably since they both refer to the process of assessing the susceptibility of bacteria to various antimicrobial agents. However, antimicrobial susceptibility testing is a broader term that includes testing against a range of antimicrobial agents, including antifungals, antivirals, and antiparasitics, whereas antibiotic sensitivity testing specifically refers to testing the efficacy of antibiotics against bacteria.

The Antimicrobial Susceptibility Testing Market Report offers valuable insights on market trends, new technologies, and investment opportunities. It helps diagnostic labs, pharmaceutical firms, and healthcare providers make informed decisions on resource allocation, R&D strategies, and collaborations in this sector.

Related Market

Antiviral and Antimicrobial Coatings Market

Read More

Antifungal Treatment Market

Read More

Antibacterial Coatings Market

Read More

Antimicrobial Suture Market

Read More

Veterinary Antimicrobial Susceptibility Testing Market

Read More
Partner

Our Clients